BIIB — Biogen Inc. Common Stock, NEUTRAL 48/100 signal

Biogen Inc. Common Stock

$214.94 ▲ +0.71% Biological Products, (No Diagnostic Substances) $31.8B

48/100

NEUTRAL

5-factor composite · mixed read

Technical (44%)60

Momentum (19%)54

Fundamental (4%)68

Options (4%)56

Microstructure (29%)48

🧠 Pattern Intelligence · backtested

50%

Based on 50 similar historical setups, 50% moved up within 5 days (avg -0.557%) · HIGH confidence

✓ Verified Track Record

42% win rate across 3,885 resolved signals — every QuantLogix signal is logged at issuance and graded against live market outcomes.

See full live analysis → Get signals like this — free

QuantLogix's 5-factor engine currently reads Biogen Inc. Common Stock (BIIB) as a neutral at 48/100 — a mixed setup. Fundamental is the strongest leg at 68/100, while microstructure lags at 48/100. In backtesting, 50% of 50 comparable historical setups moved higher within five trading days. BIIB trades in the Biological Products, (No Diagnostic Substances) sector with a $31.8B market cap.

Live 5-factor quant signal — technical, momentum, fundamental, options, and microstructure — recomputed every few minutes. Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. See the verified track record → · Browse all signal scorecards →